Trial Profile

Open-label, randomised, multi-center study investigating Cetuximab, in combination with concurrent chemo- / radiotherapy in locally advanced non-small cell lung carcinoma

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 27 Apr 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cetuximab (Primary) ; Cisplatin
Indications Non-small cell lung cancer
Focus Adverse reactions; Therapeutic Use
Acronyms RADITUX

Most Recent Events

10 Sep 2019 Results of health related quality of life presented at the 20th World Conference on Lung Cancer
09 Sep 2015 Results of 60 months follow up presented at the 16th World Conference on Lung Cancer
05 Jun 2012 Efficacy outcomes presented at the 48th Annual Meeting of the American Society of Clinical Oncology.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com